[go: up one dir, main page]

CN103239666B - Medicament for treating arthritis bone disease - Google Patents

Medicament for treating arthritis bone disease Download PDF

Info

Publication number
CN103239666B
CN103239666B CN201310197974.9A CN201310197974A CN103239666B CN 103239666 B CN103239666 B CN 103239666B CN 201310197974 A CN201310197974 A CN 201310197974A CN 103239666 B CN103239666 B CN 103239666B
Authority
CN
China
Prior art keywords
medicine
radix
ganoderma
treatment
radix angelicae
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201310197974.9A
Other languages
Chinese (zh)
Other versions
CN103239666A (en
Inventor
钟加兴
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310197974.9A priority Critical patent/CN103239666B/en
Publication of CN103239666A publication Critical patent/CN103239666A/en
Application granted granted Critical
Publication of CN103239666B publication Critical patent/CN103239666B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention discloses a medicament for treating an arthritis bone disease. The medicament mainly comprises primary medicinal materials such as gastrodia elata, lucid ganoderma, hericium erinaceus, pollen pini, cordyceps mycelia, ganoderma lucidum spore, artemisia rupestris, radix angelicae, radices sileris, myrrh, testiset penis phocae, musk, long-noded pit viper, and leech, and auxiliary medicinal materials such as golden camellia, semen strychni, notopterygium root, ginseng, frankincense, borneol, gecko, tortoise plastron, lucid ganoderma, blood scorpion and ophisaurus harti. Thus, the medicament prepared according to the formula disclosed by the invention has an obvious curative effect on the arthritis bone disease, especially has a particularly obvious treatment effect on rheumatoid arthritis, cervical spondylosis and lumbar disc herniation, and does not easily reappear after treatment, and is consolidated in curative effect, convenient and practical, and suitable for generalization and use.

Description

A kind of medicine that is used for the treatment of rheumatic osteopathia
Technical field
The present invention relates to medicine manufacture technology field, is a kind of medicine that is used for the treatment of rheumatic osteopathia specifically.
Background technology
Rheumatic osteopathia is mainly that the blood circulation causing due to wind and cold is obstructed, causes the bad disease causing of nutrition supply that comprises flesh, ligament, synovial bursa, fascia.Arthropathy outward still with swelling and moving obstacle, is outbreak and the chronic course of disease of alleviating alternately apart from pain, some patients were and can occur that disable in joint and viscera function exhaustion.When onset, onset is slow, patient before this in several weeks to the lassitude and weak of some months, lose weight, the prodrome such as anorexia, low grade fever and numb hand and foot twinge.There is subsequently arthralgia, stiff, enlargement surrounding skin is warm, flushing automatically and passive exercise all cause pain.Start one, two joint involvement, often migration.Develop into symmetry polyarthritis later and start to involve again other joint from the little joint of distal limbs.Along with the development of rheumatism, rheumatoid arthritis pathological changes, the irregular heating of patient, pulse is accelerated, significantly anemia, it is stiff and lopsided that joint becomes, and causes maimed person.Knee joint, elbow, finger, wrist become the fixing position of bending, and finger becomes subluxation laterally, and patient loses self care ability, not from bedding, is unable to stir any more and angor all day.In prior art, occur being much used for the treatment of the medicine of rheumatic osteopathia, but its therapeutic effect is not good yet.
Summary of the invention
The object of the invention is to overcome the shortcoming of above-mentioned prior art, provide a kind of and treat rheumatic osteopathia and therapeutic effect is good, the medicine of taking convenience, this kind of medicine can be manufactured to capsule, tablet, unguentum or other preparations and take.
The present invention can be achieved through the following technical solutions:
The invention discloses a kind of medicine that is used for the treatment of rheumatic osteopathia, this medicine is made up of following weight ratio raw material:
Rhizoma Gastrodiae 10～20 Ganoderma 10～20 Hericium erinaceus (Bull. Ex Fr.) Pers. 10～20 Radix Ginsengs 5～10
Pollen Pini 15～30 Cordyceps mycelium 20～30 Ganoderma spore powders 15～30
Camellia nitidissima Chi 5～10 Semen Strychni 5～10 Rhizoma Et Radix Notopterygii 5～15 Herba Achilleaes 5～10
Radix Angelicae Pubescentis 5～10 Radix Angelicae Dahuricae 10～20 Radix Saposhnikoviae 10～20 Olibanums 5～15
Myrrha 10～20 Borneolum Syntheticum 5～15 Gecko 5～10 Carapax et Plastrum Testudiniss 5～15
Testis et penis callorhini 5～15 Moschus 2～5 Scorpio 5～10 Bombyx Batryticatus 5～10
Agkistrodon 5～10 Zaocys 5～10 Ophisaurus 5～10 Agkistrodons 5～10
Scolopendra 2～5 Resina Draconis 5～10 Hirudos 5～10.
At the above-mentioned medicine that is used for the treatment of rheumatic osteopathia, the optimum weight ratio of the each raw material of its medicine is:
Rhizoma Gastrodiae 10 Ganoderma 15 Hericium erinaceus (Bull. Ex Fr.) Pers. 20 Radix Ginsengs 8
Pollen Pini 20 Cordyceps mycelium 20 Ganoderma spore powders 20
Camellia nitidissima Chi 5 Semen Strychni 6 Rhizoma Et Radix Notopterygii 8 Herba Achilleaes 10
Radix Angelicae Pubescentis 5 Radix Angelicae Dahuricae 15 Radix Saposhnikoviae 10 Olibanums 5
Myrrha 10 Borneolum Syntheticum 8 Gecko 8 Carapax et Plastrum Testudiniss 8
Testis et penis callorhini 10 Moschus 2 Scorpio 8 Bombyx Batryticatus 5
Agkistrodon 5 Zaocys 5 Ophisaurus 5 Agkistrodons 5
Scolopendra 3 Resina Draconis 5 Hirudos 10.
In the above-mentioned medicine that is used for the treatment of rheumatic osteopathia, its main each material medicine effect is as follows:
Rhizoma Gastrodiae is herbaceos perennial, is distributed in national most areas.Its dry tuber also claims Rhizoma Gastrodiae, is to commonly use and famousr and precious Chinese medicine simply, the disease such as clinical dizzy, the numb limbs and tense tendons of being used for having a headache, infantile convulsion, epilepsy, tic, tetanus.
Ganoderma claims again Ganoderma lucidum seu Japonicum, Ganoderma, Ganoderma lucidum seu Japonicum, Herba mesonae chinensis, Ganoderma, is the Herb of Polyporaceae plant Ganoderma lucidum (Leyss. Ex Fr.) Karst. or Ganoderma.Taking Ganoderma sinense Zhao Xu et Zhang drug effect as best, Ganoderma originates in east Asia, distribution in China the widest in Jiangxi, Ganoderma is as the China's tradition valuable ingredient of Chinese medicine that has thousands of years medicinal histories, possesses very high medical value, modern pharmacology through scientific research institution many decades studies confirm that, Ganoderma, for strengthening body immunity, regulates blood glucose, control blood pressure, auxiliary tumor chemoradiotherapy, hepatoprotective, the aspects such as hypnotic all have significant curative effect.
Hericium erinaceus (Bull. Ex Fr.) Pers. (formal name used at school: Hericium erinaceus), the head of outer likeness in form monkey, thereby gain the name.Spore clear, colorless, smooth surface, spherical in shape or almost spherical, the flat sweet in the mouth of its property, favourable the five internal organs, aid digestion, the effect such as nourish the body, can effectively treat the diseases such as dyspepsia, rheumatic osteopathia, gastric ulcer, antral gastritis, stomachache, flatulence and neurasthenia, can make human body improve the immunocompetence to disease simultaneously.
Cordyceps mycelium parasitizes the Hepialus larva in alpine meadow soil by the Cordyceps fungus of Hypocreales Clavicipitaceae Cordyceps, larva is ossify, under optimum conditions, go out long bar-shaped Stroma and form (being the sporophore of Cordyceps fungus and the complex that Bombyx Batryticatus sclerotium (larva corpse) forms) by Bombyx Batryticatus head end pumping summer.It contains 19 kinds of chemical compositions such as 15 kinds of trace element such as vitamin and organic acid and aminoacid, sugar, alcohols, ucleosides and potassium, calcium.Can eliminate rapidly albuminuria, edema, hematuria, anemia, hypertension for various nephropathy; Vessel softening, reduction blood fat, blood urea nitrogen, blood creatinine; Rising serum albumin, improve anemia, whole body pruritus, feel sick, the symptom such as vomiting, lassitude, and there is raising cellular immune function, activate even in addition remaining nephridial tissue, regulate body immune system, wound purifies the blood turbid, row's kidney poison; Improve kidney microenvironment, repair the effects such as kidney film.
Ganoderma spore powder all has regulating action for immune system, nervous system, E&M system and cardiovascular system etc., it contains the various active materials such as ganoderan, Ganoderma polypeptide, triterpenes, aminoacid, protein, there is following effect: strengthen immune function, prevention and treatment tumor and cancer; Reduce blood pressure, the generation of prevention cardiovascular epidemic disease; Stimulate the secretion of insulin, reduce blood sugar concentration; Accelerate blood microcirculation, improve blood oxygen ability, improve microcirculation, reduce cholesterol, can strengthen blood of human body keeping amount, promote hemetaboly, eliminate interior free yl.
Pollen Pini is the pollen of pinaceae plant Pinus massoniana Lamb, Pinus tabuliformis or its congener, cures mainly the QI invigorating of dispeling the wind, removing dampness, hemostasis.Control head and revolve dizzyly, middle void has a stomach-ache, chronic dysentery, and all skin ulcers are wet rotten, wound hemorrhage.Pollen Pini, as the hereditary material of pine genus plant, except containing the general nutrient substance such as protein, fat, saccharide, also contains multivitamin, trace element, flavone, enzyme, fatty acid and coenzyme etc. more than 200 and plants nutritional labeling and bioactive substance.After taking, can lessen fatigue in a short time, physical strength reinforcing; Constipation disappears, and digestion takes a turn for the better; Skin exquisiteness, has rosy cheeks; Sleep is steady and sure, is in a cheerful frame of mind; Energetic, memory improves.
Herba Achilleae belongs to perennial herb, the special fragrance of Herb tool, and rhizome is wooden, normal accumbency or tiltedly go up, the most nutrition branches of tool, stem is majority conventionally, rare number or single, brown or bronzing, holding of Lower Half wood, top is close by canescence pubescence; The short branch of minority is not arranged at branch or stem top, has expelling pathogenic wind from the body surface; Stomach invigorating removing food stagnancy; The effects such as promoting blood circulation to remove blood stasis.
Myrrha is the dry resin of olive subject plant Herba Violae tree or Ha Didingshu, has another name called myrrh.It is to gather the Liquid Paraffin gum resin being oozed out by bark crack place, becomes rufous and hard nahlock in air.After smashing, fry to coke black and apply.Cure mainly breast abdomen stasis of blood pain, dysmenorrhea, amenorrhea, lump in the abdomen, traumatic injury, carbuncle skin infection, acute appendicitis, conjunctival congestion and swelling pain.There is the effect such as promoting blood circulation and stopping pain, detumescence and promoting granulation.
The Radix Angelicae Dahuricae is the dry root of the samphire Radix Angelicae Dahuricae or Radix angelicae dahuricae, its meridian distribution of property and flavor: pungent, and temperature.Attach to the lung and stomach meridians.There is expelling wind and cold, understand things pain-stopping, detumescence and apocenosis, the effects such as dampness leukorrhagia stopping.Modern pharmacological research proves that the Radix Angelicae Dahuricae also has the effect such as antiinflammatory, antipyretic-antalgic simultaneously.
Radix Saposhnikoviae is the root of umbelliferae Saposhnikovia divaricata.Its effect: expelling pathogenic wind from the body surface, removing dampness to relieve pain, spasmolytic, antipruritic.Be used for the treatment of affection of exogenous wind-cold; Headache general pain; Rheumatic arthralgia; Joint is ached; Stomachache is had loose bowels; Discharging fresh blood stool; Tetanus; Rubella pruritus etc. has obvious curative effects.
Testis et penis callorhini mostly is sea dog and Phocidae animal harbor seal, puts penis and the testis of harbor seal.Testis et penis callorhini is Chinese medicine, and " sweet, temperature, nontoxic greatly." there is warming the kidney tonifying YANG, effect that benefit essence is mended marrow.Cure mainly the diseases such as deficient impairment caused by overstrain, sexual impotence essence decline, premature ejaculation, waist knee flaccidity, trusted subordinate's pain.Hirudo, popular name Hirudo, growth and breeding in the freshwater of inland, is the medicinal aquatic animal of the traditional special type of China, its dry products is concocted the rear traditional Chinese medical science and is used as medicine, and has the effects such as treatment apoplexy, hypertension, the clear stasis of blood, amenorrhea, traumatic injury.In recent years new discovery Hirudo preparation has specially good effect at control cardiovascular and cerebrovascular disease and anticancer aspect.
Agkistrodon is the dry all of Viperidae animal point kiss Pallas pit viper (Agkistrodon), dispels the wind, and dredging collateral, relieving convulsion, its sweet-salty, warm in nature; Poisonous; Enter liver, spleen channel; There is wind-damp dispelling, muscles and bones thoroughly, effect that arresting convulsion is jerked; To rheumatoid arthritis stubborn, numbness contracture, middle air port is askew, arthralgia, hemiplegia, tic spasm, tetanus, leprosy scabies, the diseases such as scrofula malignant boil have obvious curative effects.Moschus is very famous and precious medical material, contains abundant nutrition.Moisture 22.66%, ash 8.62% (wherein containing potassium, sodium, calcium, magnesium, chlorine, sulfate radical, phosphate radical etc.), chlorine-containing compound (in containing the ammonia 1.89% in ammonium carbonate 1.1%, ammonium salt.Carbamide 0.4%, amino acid nitrogen 1.077%, total nitrogen 6.16%), cholesterol 2.19%, crude fibre 0.59%, fatty acid 5.15%, muscone 1.2%.Moschus is pungent, warm, nontoxic, bitter in the mouth.Enter the heart, spleen, Liver Channel, have the function of having one's ideas straightened out, warding off dirty, dredging collateral, scattered silt.Cure mainly apoplexy, syncope due to accumulation of phlegm, infantile convulsion, attacked by pestiferous factors unhappiness, trusted subordinate's sudden pain, traumatic injury, swollen ulcer drug and there is analgesia detumescence effect.
In medicine material of the present invention, Pollen Pini and Ganoderma spore powder need to just can be used as medicine after breaking cellular wall, also by wall breaking technology, its medical value is fully used other raw material grinds powders simultaneously, could be absorbed by the body better, its wall breaking technology is prior art, and no further details to be given herein.
Manufacturing process of the present invention is as follows:
1, select dry, clean above-mentioned raw material;
2, raw material is ground into powder;
3, will comprise that the dusty raw materials such as Pollen Pini and Ganoderma spore powder process low temperature wall breaking technology is by its breaking cellular wall;
4, after fully being mixed, the raw material after breaking cellular wall obtains medicine of the present invention.
Medicine of the present invention can be manufactured to the different dosage forms such as powder, tablet, granule, capsule, solution, Emulsion, suspensoid, make patient easy to use, be easy to accept, not only drug dose is accurate, increased the stability of medicine simultaneously, sometimes also can reduce toxic and side effects, be also convenient to medicine storage, transport and carry.
The present invention compared with prior art has the following advantages:
The present invention mainly adopts Rhizoma Gastrodiae, Ganoderma, Hericium erinaceus (Bull. Ex Fr.) Pers., Pollen Pini, Cordyceps mycelium, Ganoderma spore powder, Herba Achilleae, the Radix Angelicae Dahuricae, Radix Saposhnikoviae, Myrrha, Testis et penis callorhini, Moschus moschiferous perfume (or spice), the main medicine material such as Agkistrodon and Hirudo, additional with Camellia nitidissima Chi, Semen Strychni, Rhizoma Et Radix Notopterygii, Radix Ginseng, Olibanum, Borneolum Syntheticum, Gecko, Carapax et Plastrum Testudinis, 16 kinds of ancillary drug raw materials such as Resina Draconis and Ophisaurus, the medicine of manufacturing of making to fill a prescription according to the present invention has rheumatic osteopathia is had to obvious curative effect, particularly to rheumatoid arthritis, cervical spondylosis, prolapse of lumbar intervertebral disc has especially significantly therapeutic effect, after treatment, be difficult for outbreak repeatedly, efficacy consolidation, very convenient and practical, be applicable to generally promoting the use of.
Detailed description of the invention
To be further described by multiple embodiment the present invention below:
Embodiment mono-:
The present embodiment discloses a kind of medicine that is used for the treatment of rheumatic osteopathia, the weight ratio of the each raw material of its medicine (unit of weight is to be g):
Rhizoma Gastrodiae 10 Ganoderma 15 Hericium erinaceus (Bull. Ex Fr.) Pers. 20 Radix Ginsengs 8
Pollen Pini 20 Cordyceps mycelium 20 Ganoderma spore powders 20
Camellia nitidissima Chi 5 Semen Strychni 6 Rhizoma Et Radix Notopterygii 8 Herba Achilleaes 10
Radix Angelicae Pubescentis 5 Radix Angelicae Dahuricae 15 Radix Saposhnikoviae 10 Olibanums 5
Myrrha 10 Borneolum Syntheticum 8 Gecko 8 Carapax et Plastrum Testudiniss 8
Testis et penis callorhini 10 Moschus 2 Scorpio 8 Bombyx Batryticatus 5
Agkistrodon 5 Zaocys 5 Ophisaurus 5 Agkistrodons 5
Scolopendra 3 Resina Draconis 5 Hirudos 10.
In the present embodiment, according to above-mentioned formula open prepared medicine of preparation method in the present invention, prepared pharmaceutical dosage form is capsule, each medicament capsule 0.5g, instructions of taking: warm water delivery service, treat the course for the treatment of: 2 courses for the treatment of, 30 days each courses for the treatment of, take each 2～4 every day three times.Through practical application, in the middle of number 15 people for the treatment of rheumatoid arthritis disease, wherein the obvious number of therapeutic effect is 11 people, and the number that effect is general is 3 people, and the inapparent number of therapeutic effect is 1 people.Through practical application, in the middle of number 9 people for the treatment of cervical spondylosis, wherein the obvious number of therapeutic effect is 5 people, and the number that effect is general is 2 people, and the inapparent number of therapeutic effect is 2 people.Through practical application, in the middle of number 17 people for the treatment of lumbar intervertebral disc protrusion disease, wherein the obvious number of therapeutic effect is 12 people, and the number that effect is general is 2 people, and the inapparent number of therapeutic effect is 3 people.
Embodiment bis-:
The present embodiment discloses a kind of medicine that is used for the treatment of rheumatic osteopathia, the weight ratio of the each raw material of its medicine (unit of weight is to be g):
Rhizoma Gastrodiae 15 Ganoderma 20 Hericium erinaceus (Bull. Ex Fr.) Pers. 20 Radix Ginsengs 5
Pollen Pini 30 Cordyceps mycelium 30 Ganoderma spore powders 30
Camellia nitidissima Chi 5 Semen Strychni 5 Rhizoma Et Radix Notopterygii 8 Herba Achilleaes 5
Radix Angelicae Pubescentis 5 Radix Angelicae Dahuricae 20 Radix Saposhnikoviae 15 Olibanums 10
Myrrha 15 Borneolum Syntheticum 10 Gecko 5 Carapax et Plastrum Testudiniss 5
Testis et penis callorhini 15 Moschus 5 Scorpio 10 Bombyx Batryticatus 5
Agkistrodon 10 Zaocys 5 Ophisaurus 5 Agkistrodons 5
Scolopendra 2 Resina Draconis 8 Hirudos 8.
In the present embodiment, according to above-mentioned formula open prepared medicine of preparation method in the present invention, prepared pharmaceutical dosage form is capsule, each medicament capsule 0.5g, instructions of taking: warm water delivery service, treat the course for the treatment of: 2 courses for the treatment of, 30 days each courses for the treatment of, take each 2～4 every day three times.Through practical application, in the middle of number 13 people for the treatment of rheumatoid arthritis disease, wherein the obvious number of therapeutic effect is 8 people, and the number that effect is general is 3 people, and the inapparent number of therapeutic effect is 1 people.Through practical application, in the middle of number 12 people for the treatment of cervical spondylosis, wherein the obvious number of therapeutic effect is 9 people, and the number that effect is general is 1 people, and the inapparent number of therapeutic effect is 2 people.Through practical application, in the middle of number 9 people for the treatment of lumbar intervertebral disc protrusion disease, wherein the obvious number of therapeutic effect is 8 people, and the number that effect is general is 1 people, and the inapparent number of therapeutic effect is 0 people.
Embodiment tri-:
The present embodiment discloses a kind of medicine that is used for the treatment of rheumatic osteopathia, the weight ratio of the each raw material of its medicine (unit of weight is to be g):
Rhizoma Gastrodiae 10 Ganoderma 10 Hericium erinaceus (Bull. Ex Fr.) Pers. 10 Radix Ginsengs 5
Pollen Pini 15 Cordyceps mycelium 20 Ganoderma spore powders 15
Camellia nitidissima Chi 8 Semen Strychni 8 Rhizoma Et Radix Notopterygii 10 Herba Achilleaes 8
Radix Angelicae Pubescentis 10 Radix Angelicae Dahuricae 15 Radix Saposhnikoviae 20 Olibanums 5
Myrrha 10 Borneolum Syntheticum 5 Gecko 5 Carapax et Plastrum Testudiniss 10
Testis et penis callorhini 15 Moschus 2 Scorpio 5 Bombyx Batryticatus 5
Agkistrodon 10 Zaocys 10 Ophisaurus 8 Agkistrodons 8
Scolopendra 5 Resina Draconis 5 Hirudos 5.
In the present embodiment, according to above-mentioned formula open prepared medicine of preparation method in the present invention, prepared pharmaceutical dosage form is tablet tablet, each tablet 0.25g, instructions of taking: warm water delivery service, treat the course for the treatment of: 2 courses for the treatment of, 30 days each courses for the treatment of, take each 4～6 every day three times.Through practical application, in the middle of number 9 people for the treatment of rheumatoid arthritis disease, wherein the obvious number of therapeutic effect is 6 people, and the number that effect is general is 1 people, and the inapparent number of therapeutic effect is 2 people.Through practical application, in the middle of number 11 people for the treatment of cervical spondylosis, wherein the obvious number of therapeutic effect is 8 people, and the number that effect is general is 2 people, and the inapparent number of therapeutic effect is 1 people.Through practical application, in the middle of number 18 people for the treatment of lumbar intervertebral disc protrusion disease, wherein the obvious number of therapeutic effect is 13 people, and the number that effect is general is 3 people, and the inapparent number of therapeutic effect is 2 people.
In the various embodiments described above manufacturing process, Pollen Pini and Ganoderma spore powder just can need to be used as medicine after breaking cellular wall, also by wall breaking technology, its medical value is fully used other raw material grinds powders simultaneously, could be absorbed by the body better, its wall breaking technology is prior art, and no further details to be given herein.
Manufacturing process of the present invention is as follows:
1, select dry, clean above-mentioned raw material;
2, raw material is ground into powder;
3, will comprise that the dusty raw materials such as Pollen Pini and Ganoderma spore powder process low temperature wall breaking technology is by its breaking cellular wall;
4, after fully being mixed, the raw material after breaking cellular wall obtains medicine of the present invention.
In sum, be only preferred embodiment of the present invention, not the present invention is done to any pro forma restriction; The those of ordinary skill of all industry all can by specification the above and implement swimmingly the present invention; But all those skilled in the art are not departing within the scope of technical solution of the present invention, can utilize disclosed above technology contents and a little change, the modification of making and the equivalent variations developing, be equivalent embodiment of the present invention; Meanwhile, the change of any equivalent variations that all foundations essence technology of the present invention is done above embodiment, modification and differentiation etc., within all still belonging to the protection domain of technical scheme of the present invention.

Claims (2)

1. be used for the treatment of a medicine for rheumatic osteopathia, it is characterized in that this medicine is made up of following weight ratio raw material:
Rhizoma Gastrodiae 10～20 Ganoderma 10～20 Hericium erinaceus (Bull. Ex Fr.) Pers. 10～20 Radix Ginsengs 5～10
Pollen Pini 15～30 Cordyceps mycelium 20～30 Ganoderma spore powders 15～30
Camellia nitidissima Chi 5～10 Semen Strychni 5～10 Rhizoma Et Radix Notopterygii 5～15 Herba Achilleaes 5～10
Radix Angelicae Pubescentis 5～10 Radix Angelicae Dahuricae 10～20 Radix Saposhnikoviae 10～20 Olibanums 5～15
Myrrha 10～20 Borneolum Syntheticum 5～15 Gecko 5～10 Carapax et Plastrum Testudiniss 5～15
Testis et penis callorhini 5～15 Moschus 2～5 Scorpio 5～10 Bombyx Batryticatus 5～10
Agkistrodon 5～10 Zaocys 5～10 Ophisaurus 5～10 Agkistrodons 5～10
Scolopendra 2～5 Resina Draconis 5～10 Hirudos 5～10.
2. be used for the treatment of according to claim 1 the medicine of rheumatic osteopathia, it is characterized in that the weight ratio of the each raw material of this medicine is:
Rhizoma Gastrodiae 10 Ganoderma 15 Hericium erinaceus (Bull. Ex Fr.) Pers. 20 Radix Ginsengs 8
Pollen Pini 20 Cordyceps mycelium 20 Ganoderma spore powders 20
Camellia nitidissima Chi 5 Semen Strychni 6 Rhizoma Et Radix Notopterygii 8 Herba Achilleaes 10
Radix Angelicae Pubescentis 5 Radix Angelicae Dahuricae 15 Radix Saposhnikoviae 10 Olibanums 5
Myrrha 10 Borneolum Syntheticum 8 Gecko 8 Carapax et Plastrum Testudiniss 8
Testis et penis callorhini 10 Moschus 2 Scorpio 8 Bombyx Batryticatus 5
Agkistrodon 5 Zaocys 5 Ophisaurus 5 Agkistrodons 5
Scolopendra 3 Resina Draconis 5 Hirudos 10.
CN201310197974.9A 2013-05-26 2013-05-26 Medicament for treating arthritis bone disease Active CN103239666B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310197974.9A CN103239666B (en) 2013-05-26 2013-05-26 Medicament for treating arthritis bone disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310197974.9A CN103239666B (en) 2013-05-26 2013-05-26 Medicament for treating arthritis bone disease

Publications (2)

Publication Number Publication Date
CN103239666A CN103239666A (en) 2013-08-14
CN103239666B true CN103239666B (en) 2014-09-17

Family

ID=48919769

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310197974.9A Active CN103239666B (en) 2013-05-26 2013-05-26 Medicament for treating arthritis bone disease

Country Status (1)

Country Link
CN (1) CN103239666B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101749674B1 (en) 2015-07-16 2017-06-26 콜마비앤에이치 주식회사 Composition comprising Hericium erinaceum extract for prevent, treatment or improvement of inflammatory bone joint diseases

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101450184B (en) * 2007-12-06 2011-01-19 陈振山 Plaster for treating rheumatism bone disease

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101450184B (en) * 2007-12-06 2011-01-19 陈振山 Plaster for treating rheumatism bone disease

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
彭跃钢.类风湿性关节炎中医药治疗进展.《广西中医药》.2006,第29卷(第04期),
类风湿性关节炎中医药治疗进展;彭跃钢;《广西中医药》;20060920;第29卷(第04期);1-3 *

Also Published As

Publication number Publication date
CN103239666A (en) 2013-08-14

Similar Documents

Publication Publication Date Title
CN108853366A (en) A kind of drug that can promote and improve sleep quality and its production method
CN103099833A (en) Soft capsule helpful for relieving sports fatigue and delaying aging and preparation method thereof
CN103301267B (en) Traditional Chinese medicine composition for treating hypertension and/or atherosclerosis and application thereof
CN103054990A (en) Traditional Chinese medicine for treating functional abdominal pain in children and preparation method thereof
CN103239666B (en) Medicament for treating arthritis bone disease
CN103655735B (en) One treats beriberi, the agent of skin pruritus foam washing
CN106215118A (en) Antineoplastic health preparation and preparation method thereof
CN1234401C (en) Bi-ant contained dampness dispelling and collaterals dredging medicinal capsule
CN102228648B (en) Chinese medicinal composition for treating icterohepatitis
CN102028831B (en) Traditional Chinese medicine composition for treating tumors or cancers and preparation method thereof
CN104293627A (en) Traditional Chinese medicine wine for supplying vital essence, tonifying qi and preserving health and preparation method of traditional Chinese medicine wine
CN101028445B (en) Chinese medicine for treating ichthyosis
CN102641368A (en) Traditional Chinese medicine for treating beriberi
CN102579818A (en) Traditional Tibetan medicine composition, preparation method thereof and application
CN105617268A (en) Medicine for treating scale keratinization type beriberi
CN104623532A (en) Traditional Chinese medicine composition for treating glioma and preparation method thereof
CN103381232B (en) Anticancer traditional Chinese medicine and its preparation method
CN104055900A (en) Traditional Chinese medicine composition for treating urticaria
CN102872210B (en) Traditional Chinese medicine for treating urticaria
CN108324783A (en) It is white to return ginseng Ling Donggan medicines for cancer
CN107929492A (en) A kind of strong doctor's external preparation for treating abscess and preparation method thereof
CN114796434A (en) Pill for keeping healthy qi and pathogenic factors dry
CN106421074A (en) Traditional Chinese medicine composition with anti-cancer and anti-tumor functions and preparation method thereof
CN104940777A (en) Electuary capable of treating liver-yang hyperactivity and spleen weakness type diarrhea during menstruation and preparation method thereof
CN103550467B (en) Traditional Chinese medicine composition for nursing and treating alopecia areata and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant